Professor John Mattick is challenging the orthodoxy that selfish DNA is the cornerstone of the genome. Regulatory RNA is where it's all happening, as Graeme O'Neill reports.

The spectacular images Brad Marsh is able to capture using NANO's cryo-transmission electron microscope are teaching us more about pancreatic beta cells. Fiona Wylie spoke to the man behind the microscope.

Unlisted Brisbane biotech Xenome is making a strong push into San Diego, hub of the US West Coast biotech industry, in pursuit of venture capital and big pharma partners to develop its long and diverse pipeline of conotoxin peptides from the venom of Australian cone shells.

Two new research facilities have opened their doors, one a joint venture between the University of Western Australia (UWA) and the Western Australian Institute for Medical Research (WAIMR), and the other based at the University of Queensland's Institute for Molecular Bioscience (IMB).

Bioinformatics Australia, Australia's peak body for bioinformatics, hosted by industry organisation AusBiotech, has announced its newly elected committee.

Peter Beattie talks to Graeme O'Neill about his vision of the future for Queensland bioscience.

Genome scientist Craig Venter is cruising the world in his yacht, sampling the genetic diversity of marine bacteria and microbes wafted over the oceans by intercontinental winds, and finding enough genetic treasure to keep drug-hunters in work for a few centuries.

Electron microscopists at the University of Queensland's Institute for Molecular Bioscience have spotted the first, sub-microscopic components of the molecular machinery of endocytosis -- the process by which living cells take up nutrients and particles.

Electron microscopists at the University of Queensland's Institute for Molecular Bioscience have spotted the first, sub-microscopic components of the molecular machinery of endocytosis -- the process by which living cells take up nutrients and particles.

The University of Queensland's multi-million dollar exit from unlisted Brisbane biotech Xenome has led to the establishment of a new $750,000 proof-of-concept fund for reinvestment in commercially viable research projects at UQ's Institute for Molecular Bioscience.

Researchers have discovered that taipan venom contains potent peptides that may prevent death from congestive heart disease.